Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:40 PM
Ignite Modification Date:
2025-12-24 @ 12:40 PM
NCT ID:
NCT05050461
Eligibility Criteria:
Inclusion Criteria:
* Adult aged at least 18 years old
* Having received (at least) two injections of anti-SARS-CoV-2 messenger RNA vaccine (Pfizer and / or Moderna)
* Affiliated to social security
* consenting to the study
* Concenring cases only: Be or have been affected by B-NHL in remission, active surveillance or during first-line or second-line treatment, regardless of this treatment
Exclusion Criteria:
Patient less than 18 years old
* Patient with protective measure (curatorship, guardianship, safeguard of justice, deprived of liberty, in an emergency situation)
* Patient unable to express their consent
* Pregnant or breastfeeding woman
* Patient refusing to participate
* Concenring cases: Patient whose life expectancy related to B-NHL is less than 6 months, History of allogeneic hematopoietic stem cell transplantation
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05050461
Study Brief:
Protocol Section:
NCT05050461